Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2005

Simmons WJ, Koneru M, Mohindru M, Thomas R, Cutro S, Singh P, et al. Tim-3+ T-bet+ tumor-specific Th1 cells colocalize with and inhibit development and growth of murine neoplasms. J Immunol. 2005;174(3):1405-15.

Lucarelli MR, Allen JN, Magro CM. Plasma cell mucositis of the distal airways. Thorax. 2005;60(2):173.

Magro CM, Calomeni EP, Nadasdy T, Shusterman BD, Pope-Harman AL, Ross P. Ultrastructure as a diagnostic adjunct in the evaluation of lung allograft biopsies. Ultrastruct Pathol. 2005;29(2):95-106.

Wooten MW, Geetha T, M Seibenhener L, J Babu R, Diaz-Meco MT, Moscat J. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. J Biol Chem. 2005;280(42):35625-9.

Gu Z, Rubin MA, Yang Y, Deprimo SE, Zhao H, Horvath S, et al. Reg IV: a promising marker of hormone refractory metastatic prostate cancer. Clin Cancer Res. 2005;11(6):2237-43.

Schlesinger N, Schlesinger M, Seshan SV. Seasonal variation of lupus nephritis: high prevalence of class V lupus nephritis during the winter and spring. J Rheumatol. 2005;32(6):1053-7.

Luo J, Sobkiw CL, Logsdon NM, Watt JM, Signoretti S, O'Connell F, et al. Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase. Proc Natl Acad Sci U S A. 2005;102(29):10238-43.

Ogino S, Meyerhardt JA, Cantor M, Brahmandam M, Clark JW, Namgyal C, et al. Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer. Clin Cancer Res. 2005;11(18):6650-6.

Ying H, Chang DL, Zheng H, McKeon F, Xiao Z-. DNA-binding and transactivation activities are essential for TAp63 protein degradation. Mol Cell Biol. 2005;25(14):6154-64.

Magro CM, Ross P. Endobronchial mimics of primary endobronchial carcinoma: a clinical study of 25 cases. Can Respir J. 2005;12(3):123-7.